CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bijoy Hans Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bijoy Hans Ltd
PATAWARI NIWAS
H P BRAHMACHARI ROAD, REHABARI
Phone: +91 3612512373p:+91 3612512373 GUWAHATI, 781008  India Ticker: 524723524723
Business Summary
Bijoy Hans Limited is an India-based company. The Company is mainly engaged in the business of trading in bulk drugs, pharmaceuticals, cosmetics, and investment. The Company offers various pharmaceutical formulations, such as tablets, capsules, syrups, suspension and powders, focusing on segments, such as ANTIBIOTICS, COUGH/COLD/ALLERGY, H-1RECEPTOR ANTAGONIST (ANTIULCERANT), NUTRACEUTICALS, and NSAIDS.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

General Information
Outstanding Shares: 3,000,021 (As of 9/30/2024)
Stock Exchange: BOM
Fax Number: +91 3612548386


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 20, 2025